药剂师对儿童喘的干预:一个系统的文献综述和逻辑模型模型
Guohua Lin1, Chi Ian Chau1, Hao Hu2
1State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macao.
Research in social & administrative pharmacy : RSAP
|September 7, 2023
概括
药剂师主导的干预措施通过优化药物使用和预防来改善儿科喘管理. 一个逻辑模型指导基于证据的药房实践,以更好地遵守,控制和提高生活质量.
科学领域:
- 儿科肺病学 儿科肺病学
- 药房实践 在药房实践.
- 医疗保健服务研究 医疗服务研究
背景情况:
- 儿童喘是一个重大的公共卫生问题.
- 新出现的证据支持药剂师主导的干预措施来管理儿童喘.
- 优化护理需要了解有效的干预组件.
研究的目的:
- 系统地审查药剂师主导的儿童喘干预的证据.
- 开发一个基于证据的儿科喘药房实践的逻辑模型.
- 确定关键的干预组件,结果和背景因素.
主要方法:
- 在多个数据库 (PubMed,科学网,Embase,Scopus等) 中进行全面的文献搜索. ) 的情况.
- 包括2013年1月至2023年2月期间发表的关于儿科喘的干预研究,遵守PRISMA指南.
- 将干预组件编译成一个逻辑模型框架 (输入,活动,输出,结果,上下文).
主要成果:
- 从2291个初始记录中分析了35项研究.
- 关键的干预活动集中在优化药物使用和喘控制上.
- 经常报告的结果包括改善药物坚持,知识,吸入器技术,喘控制得分,肺功能,生活质量和成本降低.
结论:
- 一个逻辑模型有效地总结了药剂师领导的儿科喘干预措施.
- 这个模型作为一个蓝图,以证据为基础的药房实践在儿科喘管理.
- 未来的研究应该探索药剂师在多学科团队和护理过渡中的角色.
相关概念视频
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
Asthma: Pathogenesis and Management
439
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
439
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
332
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
332


